Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2014
12/09/2014US8906902 Antibacterial compounds
12/09/2014US8906885 Treating cancer with HSP90 inhibitory compounds
12/09/2014US8906521 Organic electroluminescent device having triptycene derivative material
12/09/2014US8906518 Triazole derivative, light-emitting element, light-emitting device, and electronic device
12/04/2014US20140357858 P2x4 receptor antagonist
12/04/2014US20140357675 Substituted Phenylazole Derivatives
12/04/2014US20140357653 Chemical compounds
12/04/2014US20140357650 Novel fap inhibitors
12/04/2014US20140357634 Substituted 4-aminocyclohexane derivatives
12/04/2014US20140357632 Benzopiperazine derivatives as cetp inhibitors
12/04/2014US20140357629 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140357614 Diamino-Pyridine, Pyrimidine, and Pyrazine Modulators of the Histamine H4 Receptor
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901308 Triazole compounds that modulate Hsp90 activity
12/02/2014US8901304 Benzo[D]imidazole derivatives of piperidine and piperazine
12/02/2014US8901295 Inhibitors of cyclophilins and uses thereof
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901146 Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
12/02/2014US8901143 Pyrimidine derivatives
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901124 Pyridazine amide compounds useful as SYK inhibitors
12/02/2014US8901121 Metalloenzyme inhibitor compounds
12/02/2014US8901120 Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
12/02/2014US8900785 Charge control agent and toner using the same
12/02/2014US8900566 Hepatitis C virus inhibitors
11/2014
11/27/2014US20140350252 Process for the preparation of voriconazole and intermediates thereof
11/27/2014US20140350250 Therapeutic agent for cerebral infarction
11/27/2014US20140350249 Therapeutic agent for cerebral infarction
11/27/2014US20140350248 Chemical entities and therapeutic uses thereof
11/27/2014US20140350030 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same
11/27/2014US20140350016 Potent and selective inhibitors of hepatitis c virus
11/27/2014US20140349997 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349987 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
11/27/2014US20140349986 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
11/27/2014US20140349973 Metalloenzyme inhibitor compounds
11/27/2014US20140348746 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
11/25/2014US8895759 Intermediates useful in the preparation of maleimide functionalized polymers
11/25/2014US8895755 Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
11/25/2014US8895688 Halogen-free flame retarding materials based on bisphenol triazole resins and polymers
11/25/2014US8895602 6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors
11/25/2014US8895601 Pyrazolyl quinoxaline kinase inhibitors
11/25/2014US8895596 Cyclic benzimidazole derivatives useful as anti-diabetic agents
11/25/2014US8895589 Pyridinyl amides as P2X3 and P2X2/3 inhibitors
11/25/2014US8895574 Benzyloxypyrimidine derivative, agricultural/ horticultural insecticide comprising derivative and method for using same
11/25/2014US8895573 Phenoxy-substituted pyrimidines as opioid receptor modulators
11/25/2014US8895571 Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
11/25/2014US8895566 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
11/25/2014US8895559 Quinoxalines derivatives and pharmaceutical compositions and kits
11/25/2014US8895556 Compounds and method for treatment of cancer
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/25/2014US8895035 Alkoxyimino derivative and pest control agent
11/20/2014US20140343295 Novel 6-pyrazolylamido-3-substituted azabicyclo[3.1.0]hexane compounds as calcium channel inhibitors
11/20/2014US20140343286 Anti-viral compounds
11/20/2014US20140343278 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343094 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/20/2014US20140343083 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343070 Proton pump inhibitors
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343061 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343030 Bipyrazole derivatives as jak inhibitors
11/20/2014US20140343018 Anti-depression Compounds
11/20/2014US20140343017 Pyrrole compound
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140342906 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/20/2014US20140339462 Stilbene optical brighteners
11/18/2014US8889887 Pentamethine cyanine fluorescent dyes, preparation methods and uses thereof
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889863 Stereoselective methods, catalysts and intermediates for the synthesis of (−)-Nutlin-3 and related compounds
11/18/2014US8889741 Cycloalkane derivatives
11/18/2014US8889730 Indole and indazole compounds that activate AMPK
11/18/2014US8889726 Chemica compounds
11/18/2014US8889709 Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889692 Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
11/18/2014US8889688 Piperazines as antimalarial agents
11/18/2014US8889683 Substituted quinoxalines as inhibitors of fatty acid binding protein
11/18/2014US8889677 Substituted triazoles useful as mGlu5 receptor modulators
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889673 Triazolopyridine JAK inhibitor compounds and methods
11/18/2014US8889665 Chemical compounds
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336381 Fast-dissociating dopamine 2 receptor antagonists
11/13/2014US20140336376 Pharmaceutical composition for treating diabetes
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336211 Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-Indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl ] -amide
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336170 Indazole compounds useful as ketohexokinase inhibitors
11/13/2014US20140336165 Dihydroxy aromatic heterocyclic compound
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 626